<DOC>
	<DOC>NCT00976716</DOC>
	<brief_summary>To investigate efficacy, safety and tolerability of Celecoxib in patients with posttraumatic pain for the duration of 8 days.</brief_summary>
	<brief_title>An Open-Label Study Of Celecoxib In Patients With Posttraumatic Pain</brief_title>
	<detailed_description />
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Patients with posttraumatic pain which is able to be controlled with an oral NSAID Patients with "pain" that meets both of the following criteria within 48 hours after injury: "Pain" Pain intensity (Categorical): "Moderate pain" or "Severe pain" Pain intensity (VAS): 45.0 mm or more Patients with "inflammation" that meets the following criteria within 48 hours after injury. "Inflammation" Categorical: "Mild", "Moderate" or "Severe" Patients who have received analgesics and anaesthetics for injury Patients with a history/complication of aspirininduced asthma Patients taking excluded medications Patients with a history/complication of ischaemic heart disease, serious cardiac arrhythmias, cardiac failure congestive and cerebrovascular disorder or with a history/plan of revascularization</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>posttraumatic pain</keyword>
</DOC>